Quantcast

4 Reasons AbbVie Could Crush The Market Over The Next Decade

Posted On May 31, 2018 6:18 am
By:

AbbVie is a leader in the complex and fast changing biotech industry. What’s more there are four reasons why this high-yield blue chip should be able to easily generate 15% annualized total returns over the next decade, nearly doubling the market’s likely returns.

Continue Reading Here

About author

Dividend Sensei
Dividend Sensei

I'm an Army veteran and former energy dividend writer for The Motley Fool. I currently write for both Seeking Alpha, Simply Safe Dividends, and DividendSensei.com My goal is to help all people learn how to harness the awesome power of dividend growth investing to achieve their financial dreams, and enrich their lives. With 22 years of investing experience, I've learned what works and more importantly, what doesn't, when it comes to building long-term wealth and income streams. I'm currently on an epic quest to build a broadly diversified, high-quality, high-yield dividend growth portfolio that: 1. Pays a 5% yield 2. Offers 7% annual dividend growth 3. Pays dividends AT LEAST on a weekly, but preferably, daily basis

Related Articles